Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study

• Main Authors: Andrea Chiricozzi (Author), Giacomo Dal Bello (Author), Niccolò Gori (Author), Lucia Di Nardo (Author), Donatella Schena (Author), Giacomo Caldarola (Author), Martina Maurelli (Author), Clara De Simone (Author), Giampiero Girolomoni (Author), Ketty Peris (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Dupilumab is a monoclonal antibody against the IL-4/IL-13 receptor-subunit approved for the treatment of moderate-severe atopic dermatitis (AD). Some attempts to increase dose interval have been described in both trial and real-world settings. Objective This study aimed to identify predic...